Diabetes Board decisions

The Veteran's asthma, tinnitus, and related conditions are now service-connected. The Board has determined that additional examinations and remands are necessary for further analysis of the remaining issues.

The Veteran's claim for a higher disability rating for diabetes mellitus was denied as the evidence did not show that he required regulation of activities to manage his diabetes.,The Veteran's claims for an initial compensable disability rating for bilateral hearing loss prior to March 22, 2023 and a disability rating higher than 20 percent for bilateral hearing loss from March 22, 2023 were denied as the evidence did not show that he required regulation of activities to manage his diabetes.,The Veteran's claim for an initial disability rating higher than 10 percent for bilateral cataracts with diabetic retinopathy prior to March 30, 2023 and a disability rating higher than 50 percent for bilateral cataracts with diabetic retinopathy from March 30, 2023 was denied as the evidence did not show that he required regulation of activities to manage his diabetes.,The Veteran's claim for a total disability rating based upon individual unemployability prior to March 30, 2023 was remanded.

The Board has denied service connection for diabetes mellitus type II and remanded the issue of service connection for a heart disability. The decision on diabetes is due to lack of herbicide exposure, while the heart disability case requires further examination.

The Veteran's initial claim for an increased evaluation for bilateral hearing loss prior to March 1, 2016 was denied. An initial 10 percent evaluation is granted from March 1, 2016 to December 2, 2022.,An initial evaluation in excess of 10 percent for bilateral hearing loss from March 1, 2016 is denied.

The Veteran's bilateral hearing loss, tinnitus, hypertension (HTN), and diabetes mellitus, type II (DM II) are all granted as service-connected due to exposure to PFAS in contaminated drinking water at Fort Huachuca, Arizona.

The Board has remanded the claims of diabetic neuropathy and service connection for diabetic nephropathy. The Veteran's diabetes mellitus type II is currently rated at 20 percent, but the Board finds that a higher rating is not warranted due to his current treatment regimen.

The Veteran's claims for service connection are remanded due to the need for further development regarding his exposure to herbicide agents while stationed on C-123 aircraft in Korea and Japan.

The Board has decided to remand the case due to a duty-to-assist error, and will need an addendum opinion regarding the nature and etiology of the Veteran's erectile dysfunction.

The Veteran's service-connected diabetes mellitus type II and coronary artery disease were found to be contributory causes of his death from metastatic cancer, leading to the grant of DIC benefits.

The Veteran's diabetes mellitus, type II is presumed to be related to his exposure to herbicide agents during service at Nakhon Phanom Royal Thai Air Force Base in Thailand. The Board granted service connection for this condition.

The Board has remanded the case due to the need for an expert medical opinion regarding whether the Veteran's service-connected disabilities have caused or aggravated his hyperlipidemia, and if so, whether this condition has caused or aggravated any of his other conditions beyond its natural progression.

The Veteran's claim of service connection for migraine headaches is being remanded due to the need for a VA opinion regarding whether his current migraines are caused or aggravated by his service-connected diabetes, hypertension, or PTSD.

The Board has identified a duty-to-assist error in the July 2022 decision and has ordered that the claims for diabetes mellitus and glaucoma of the right eye as secondary to diabetes mellitus be remanded to obtain VA treatment records from 1965 to 2003.

The Veteran's TDIU claim was denied as he did not establish entitlement to a combined rating of at least 70% for his service-connected disabilities prior to February 26, 2020.,The DEA claim was also denied due to the denial of the TDIU claim and the effective date assigned for the TDIU.

The Board has granted service connection for nephrotic syndrome and dismissed the claim for diabetes. The Veteran's nephrotic syndrome is found to be related to in-service exposure to toxic chemicals, while his diabetes was not connected to service.

The Veteran's claims for service connection for diabetes mellitus, type II (DM II) and prostate cancer are remanded due to insufficient information regarding his exposure to herbicide agents during active duty in the Republic of Korea.

The Veteran's diabetes mellitus type II, right arm neuropathy, left arm neuropathy, right leg lower neuropathy, and left leg lower neuropathy are all granted as service connected. The Board found that the Veteran's current conditions were related to his in-service onset of diabetes.

The Board has identified three pre-decisional duty to assist errors and has therefore remanded the claims for further development. Specifically, the AOJ did not attempt to obtain the Veteran's private treatment records, the September 2023 VA Examination for diabetes mellitus is inadequate, and the September 2023 VA Examination for peripheral neuropathy is also inadequate.

Your claim for service connection for diabetes mellitus, type II has been granted and effective since April 2013. However, the appeal is dismissed as moot because no further disagreement was expressed regarding the rating or effective date.

The Board has remanded the claims for ischemic heart disease, arthritis of all joints, diabetes mellitus type II, and bilateral upper and lower extremity peripheral neuropathy due to potential exposure to toxic chemicals during service. The Veteran is also requested to undergo VA examinations to determine the nature, onset, and etiology of his claimed multi-joint arthritis, chronic pain, and gout condition.